Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252
Clinical trial NCT06126744 · RECRUITING
Trial details
- NCT number
- NCT06126744
- Sponsor
- Duke University
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-11
- Primary completion
- 2027-12-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.